---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-058063"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2026-02-19T23:59:59+00:00"
generated_at: "2026-05-16T01:54:43.332977+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Q4 EPS $0.40; Adj. EPS $0.50; guides 2026 EBITDA $280-300M

## Summary
- Net revenue $494M, down slightly YoY; same-unit revenue up 4.0%.
- Q4 GAAP net income $33.7M ($0.40/share) vs $30.5M ($0.36) prior year; Adjusted EPS $0.50.
- Full year 2025 Adjusted EBITDA $275.6M, up from $224M; Adjusted EPS $2.04 vs $1.51.
- Preliminary 2026 Adjusted EBITDA guidance $280-300M, above 2025's $275.6M.
- Cash from operations $114.6M in Q4; used $64M for share repurchases; total debt $597M.

## SEC filing metadata
- accession: 0001193125-26-058063
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2026-02-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312526058063/0001193125-26-058063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312526058063/md-20260219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-058063
- JSON: https://secwatch.observer/filing/0001193125-26-058063.json
- Plain text: https://secwatch.observer/filing/0001193125-26-058063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.